The prescription drug landscape is changing in an unprecedented way. Economic recession related austerity measures and budget challenges motivate payers to act on long-standing concerns that ...
-Zydus launches 'Tenglyn', the most affordable gliptin for diabetics in India -Cadila Healthcare has splits its face value from Rs. 5 to Rs. 1 2016 -Zydus Cadila acquires select animal health brands ...